Sofpironium bromide gel, 15% was generally well-tolerated
Plan to submit a New Drug Application (NDA) to the FDA in mid-2022
Management to host webcast and conference call today at 8:30 a.m. ET to present the topline results
Conference Call and Webcast Information
Brickell’s management will host a webcast and conference call today at 8:30 a.m. ET to discuss the topline data announced in this release. The dial-in number for the conference call is 1-877-705-6003 for domestic participants and 1-201-493-6725 for international participants, with Conference ID #13723931. A live webcast of the conference call can be accessed here or through the “Investors” tab on the Brickell Biotech website at https://www.brickellbio.com. A replay will be available on this website shortly after conclusion of the event for approximately 90 days.
https://finance.yahoo.com/news/brickell-biotech-announces-positive-topline-105500385.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.